Nicotinamide Mononucleotide Ameliorates Sleep Deprivation‐Induced Gut Microbiota Dysbiosis and Restores Colonization Resistance against Intestinal Infections
Advanced Science · 2023
DOI: 10.1002/advs.202207170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Dan Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, P. R. China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Jiangsu Agricultural Science and Technology Innovation Fund.
Abstract (Originalsprache)
Gut microbiota‐mediated colonization resistance (CR) is crucial in protecting the host from intestinal infections. Sleep deprivation (SD) is an important contributor in the disturbances of intestinal homeostasis. However, whether and how SD affects host CR remains largely unknown. Here, it is shown that SD impairs intestinal CR in mice, whereas nicotinamide mononucleotide (NMN) supplementation restores it. Microbial diversity and metabolomic analyses suggest that gut microbiota and metabolite profiles in SD‐treated mice are highly shaped, whereas NMN reprograms these differences. Specifically, the altered gut microbiota in SD mice further incurs the disorder of secondary bile acids pool accompanied by a decrease in deoxycholic acid (DCA). Conversely, NMN supplementation retakes the potential benefits of DCA, which is associated with specific gut microbiota involved in primary bile acids metabolic flux. In animal models of infection, DCA is effective in preventing and treating bacterial infections when used alone or in combination with antibiotics. Mechanistically, DCA alone disrupts membrane permeability and aggravates oxidative damage, thereby reducing intestinal pathogen burden. Meanwhile, exogenous DCA promotes antibiotic accumulation and destroys oxidant–antioxidant system, thus potentiating antibiotic efficacy. Overall, this work highlights the important roles of gut microbiota and bile acid metabolism in the maintenance of intestinal CR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, P. R. China.
- Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Joint International Research Laboratory of Agriculture and Agri-Product Safety the Ministry of Education of C…
- Institute of Comparative Medicine, Yangzhou University, Yangzhou, 225009, P. R. China.
ORCID-Profile: Yuan Liu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Jiangsu Agricultural Science and Technology Innovation Fund
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Young Elite Scientists Sponsorship Program by CAST
Zitieren
APA
Fang, D., Xu, T., Sun, J., Shi, J., Li, F., Yin, Y., Wang, Z., & Liu, Y. (2023). Nicotinamide Mononucleotide Ameliorates Sleep Deprivation‐Induced Gut Microbiota Dysbiosis and Restores Colonization Resistance against Intestinal Infections. Advanced Science. https://doi.org/10.1002/advs.202207170
Vancouver
Fang D, Xu T, Sun J, Shi J, Li F, Yin Y, et al. Nicotinamide Mononucleotide Ameliorates Sleep Deprivation‐Induced Gut Microbiota Dysbiosis and Restores Colonization Resistance against Intestinal Infections. Advanced Science. 2023. doi:10.1002/advs.202207170
BibTeX
@article{Fang2023,
author = {Fang, Dan and Xu, Tianqi and Sun, Jingyi and Shi, Jingru and Li, Fulei and Yin, Yanqing and Wang, Zhiqiang and Liu, Yuan},
title = {Nicotinamide Mononucleotide Ameliorates Sleep Deprivation‐Induced Gut Microbiota Dysbiosis and Restores Colonization Resistance against Intestinal Infections},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202207170}
}
EUVIMED